Literature DB >> 8622728

Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection.

R L Rosales1, K Arimura, S Takenaga, M Osame.   

Abstract

The effects of botulinum toxin-A was compared on both extrafusal and intrafusal muscle fibers in the biceps femoris of Wistar rats. Four days after injection no action potentials were elicited with stimulation single-fiber electromyography on the injected side. Fourteen days after injection, jitter became measurable and these values were increased on the injected side. Extrafusal muscle fibers began to atrophy on the 4th day and this continued to the 14th day postinjection. Atrophy was also evident and progressive in intrafusal muscle fibers. Increased terminal innervation ratios, end-plate spread of cholinesterase, and increased density of very small myelinated fibers in large intramuscular nerves were observed 14 days postinjection. Both extrafusal and intrafusal fibers are cholinergically innervated, and both were progressively affected by botulinum toxin, perhaps varying in degree only. In addition to partial denervation, Botulinum toxin effects in dystonia may also be related to modified spindle afferent discharge.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8622728     DOI: 10.1002/(SICI)1097-4598(199604)19:4<488::AID-MUS9>3.0.CO;2-8

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  68 in total

1.  Mechanism of Botulinum Toxin in the Relief of Chronic Pain.

Authors: 
Journal:  Curr Rev Pain       Date:  1999

Review 2.  [Use of botulinum toxin the the treatment of muscle pain].

Authors:  R Benecke; D Dressler; E Kunesch; T Probst
Journal:  Schmerz       Date:  2003-12       Impact factor: 1.107

Review 3.  Is there a role for botulinum toxin in the treatment of migraine?

Authors:  Stefan Evers
Journal:  Curr Pain Headache Rep       Date:  2003-06

4.  The changed image of botulinum toxin.

Authors:  V Peter Misra
Journal:  BMJ       Date:  2002-11-23

Review 5.  Botulinum toxin for the treatment of movement disorders.

Authors:  Mary Ann Thenganatt; Stanley Fahn
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

6.  [Pharmacology of botulinum toxin drugs].

Authors:  D Dressler
Journal:  HNO       Date:  2012-06       Impact factor: 1.284

Review 7.  [Botulinum toxin therapy in orthopaedics].

Authors:  L Döderlein
Journal:  Orthopade       Date:  2006-01       Impact factor: 1.087

8.  Regulation of gephyrin cluster size and inhibitory synaptic currents on Renshaw cells by motor axon excitatory inputs.

Authors:  David Gonzalez-Forero; Angel M Pastor; Eric J Geiman; Beatriz Benítez-Temiño; Francisco J Alvarez
Journal:  J Neurosci       Date:  2005-01-12       Impact factor: 6.167

Review 9.  Phenomenology, genetics, and CNS network abnormalities in laryngeal dystonia: A 30-year experience.

Authors:  Andrew Blitzer; Mitchell F Brin; Kristina Simonyan; Laurie J Ozelius; Steven J Frucht
Journal:  Laryngoscope       Date:  2017-12-08       Impact factor: 3.325

10.  Effects of botulinum toxin type A on vibration induced facilitation of motor evoked potentials in spasmodic torticollis.

Authors:  P P Urban; R Rolke
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-11       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.